Published in Cancer Biol Ther on May 10, 2013
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget (2015) 1.17
How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol (2015) 1.16
miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression. PLoS One (2014) 1.05
Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death Dis (2013) 0.99
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med (2016) 0.89
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death. Cell Death Dis (2014) 0.88
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Int J Oncol (2015) 0.87
MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma. Oncotarget (2015) 0.85
Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis. Sci Rep (2014) 0.82
Epigenetic control of autophagy by microRNAs in ovarian cancer. Biomed Res Int (2014) 0.81
MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Int J Clin Exp Pathol (2015) 0.78
Atg7 in development and disease: panacea or Pandora's Box? Protein Cell (2015) 0.78
Autophagy-Regulating microRNAs and Cancer. Front Oncol (2017) 0.78
microRNA-17-5p Modulates Bacille Calmette-Guerin Growth in RAW264.7 Cells by Targeting ULK1. PLoS One (2015) 0.77
MicroRNAs: an emerging player in autophagy. ScienceOpen Res (2014) 0.77
Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes. Int J Mol Sci (2016) 0.77
Regulation of B Cell Differentiation by Intracellular Membrane-Associated Proteins and microRNAs: Role in the Antibody Response. Front Immunol (2015) 0.77
Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress. J Transl Med (2016) 0.76
MicroRNA regulation of autophagy in cardiovascular disease. Front Biosci (Landmark Ed) (2017) 0.76
Nerve growth factor-induced Akt/mTOR activation protects the ischemic heart via restoring autophagic flux and attenuating ubiquitinated protein accumulation. Oncotarget (2016) 0.75
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism. Front Physiol (2016) 0.75
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression. Sci Rep (2016) 0.75
Emerging connections between RNA and autophagy. Autophagy (2016) 0.75
Identification of Autophagy-Related Genes and Their Regulatory miRNAs Associated with Celiac Disease in Children. Int J Mol Sci (2017) 0.75
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression. Oncogene (2016) 0.75
miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7. Med Mol Morphol (2016) 0.75
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
A uniform system for microRNA annotation. RNA (2003) 20.28
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60
Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet (2009) 14.06
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem (1998) 10.77
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform (2011) 8.50
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res (2004) 7.96
Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol (2010) 7.15
Molecular evolution of a microRNA cluster. J Mol Biol (2004) 5.94
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 5.49
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol (2006) 3.71
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One (2008) 3.68
Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem (2011) 3.15
mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol (2010) 3.15
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy (2010) 2.62
New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res (2009) 2.56
The mTOR signalling pathway in human cancer. Int J Mol Sci (2012) 2.38
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol (2008) 2.29
MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A (2008) 2.24
Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy (2009) 2.09
microRNA-101 is a potent inhibitor of autophagy. EMBO J (2011) 2.00
Human glioma growth is controlled by microRNA-10b. Cancer Res (2011) 1.96
A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One (2011) 1.87
Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist (2007) 1.85
The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med (2009) 1.43
MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem (2011) 1.36
miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology (2012) 1.36
MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol (2012) 1.35
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res (2012) 1.33
miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology (2010) 1.32
Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One (2012) 1.20
A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther (2011) 1.17
Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene (2012) 1.15
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg (2009) 1.11
The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) (2009) 1.10
MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy (2012) 1.10
Autophagy and ionizing radiation in tumors: the "survive or not survive" dilemma. J Cell Physiol (2013) 1.07
Therapeutic exploitation of apoptosis and autophagy for glioblastoma. Anticancer Agents Med Chem (2010) 0.98
Novel therapies in glioblastoma. Neurol Res Int (2012) 0.97
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy (2011) 0.95
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem (2012) 0.94
Unified translation repression mechanism for microRNAs and upstream AUGs. BMC Genomics (2010) 0.90
Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J (2012) 0.89
MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network Involving miR-17-92. PLoS One (2011) 0.88
The miR-290-295 cluster suppresses autophagic cell death of melanoma cells. Sci Rep (2012) 0.88
The intriguing life of autophagosomes. Int J Mol Sci (2012) 0.83
TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. Int J Cancer (2011) 0.81
AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells. Eur J Histochem (2012) 0.81
Transcriptional activation by small RNA duplexes. Nat Chem Biol (2007) 0.79
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol (2007) 2.25
β-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol Ther (2011) 1.73
Neuroradiological follow-up of the growth of papillary tumor of the pineal region: a case report. J Neurooncol (2009) 1.65
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases. Cancer Immunol Immunother (2009) 1.36
The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy (2009) 1.35
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme. Cancer Immunol Immunother (2013) 1.30
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biol Ther (2013) 1.26
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy). Cancer Immunol Immunother (2010) 1.24
Presacral ganglioneuroma: a case report and review of literature. World J Gastroenterol (2007) 1.20
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy. Cancer Immunol Immunother (2011) 1.19
Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res (2008) 1.14
Telomere length and obesity. Acta Paediatr (2008) 1.10
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol (2002) 1.08
Intradural extramedullary spinal anaplastic ependymoma. Case illustration. J Neurosurg Spine (2006) 1.08
Development of a mouse model for the study of Toscana virus pathogenesis. Virology (2005) 1.00
Ozonated sesame oil enhances cutaneous wound healing in SKH1 mice. Wound Repair Regen (2010) 0.97
Orbital glomangioma. Orbit (2012) 0.96
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy (2011) 0.95
Emerging roles of microRNA in modulating cell-death processes in malignant glioma. J Cell Physiol (2014) 0.94
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem (2012) 0.94
Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis. Mod Pathol (2008) 0.93
Autophagy is modulated in human neuroblastoma cells through direct exposition to low frequency electromagnetic fields. J Cell Physiol (2014) 0.92
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). Neuro Oncol (2012) 0.91
Cigarette smoke affects keratinocytes SRB1 expression and localization via H2O2 production and HNE protein adducts formation. PLoS One (2012) 0.91
Primary cutaneous aspergillosis in an immunocompetent patient. Mycoses (2003) 0.90
Nucleolin protein expression in cutaneous melanocytic lesions. J Cutan Pathol (2009) 0.86
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients. Cancer Immunol Immunother (2015) 0.86
S100A13 is a new angiogenic marker in human melanoma. Mod Pathol (2010) 0.86
Photobiomodulation improves cutaneous wound healing in an animal model of type II diabetes. Photomed Laser Surg (2004) 0.86
Supratentorial neurenteric cyst associated with a intraparenchymal subependymoma. BMJ Case Rep (2012) 0.83
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study. Cancer Immunol Immunother (2015) 0.83
Automated diagnosis of pigmented skin lesions. Int J Cancer (2002) 0.83
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy. Radiology (2012) 0.82
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys (2006) 0.81
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells. J Cell Physiol (2014) 0.81
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression. Int J Oncol (2003) 0.80
Spindle cell lipoma of the orbit: a case report of an unusual orbital pathology. Neurol Neurochir Pol (2010) 0.80
Myelodysplasia presenting as thoracic spinal epidural extramedullary hematopoiesis: a rare treatable cause of spinal cord myelopathy. Skeletal Radiol (2011) 0.80
Altered cellular distribution and sub-cellular sorting of doppel (Dpl) protein in human astrocytoma cell lines. Cell Oncol (2008) 0.80
Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Cell Biol Int (2012) 0.79
Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma. Hum Pathol (2009) 0.79
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes. Strahlenther Onkol (2014) 0.79
Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens. J Biomed Biotechnol (2009) 0.79
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Hum Pathol (2007) 0.79
Intracranial epidermoid cyst: case report. Ann Ital Chir (2009) 0.79
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes. Neuro Oncol (2010) 0.79
Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology (2011) 0.78
Cutaneous metastases from adenocarcinoma of the rete testis. J Cutan Pathol (2006) 0.77
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer. J Soc Gynecol Investig (2004) 0.77
Biochemical signatures of doppel protein in human astrocytomas to support prediction in tumor malignancy. J Biomed Biotechnol (2010) 0.76
Emerging Targets For Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach. Curr Drug Targets (2016) 0.76
Association of nevus of Jadassohn, sebaceoma and trichoblastoma in a scalp lesion. Acta Dermatovenerol Croat (2011) 0.76
New neurocutaneous syndrome with defect in cell trafficking and melanosome pathway: the future challenge. Brain Dev (2008) 0.75
[Extratesticular intraescrotal neurofibroma: case report]. Arch Esp Urol (2006) 0.75
A single centre melanoma thickness trend (1985-2009) in relation to skin areas accessible and non-accessible to self-inspection. Australas J Dermatol (2011) 0.75
A nodule on a boy's back. Arch Dermatol (2007) 0.75
Subcutaneous panniculitis lymphoma: erythema nodosum-like. Clin Lymphoma Myeloma (2006) 0.75
An unusual case of tinea capitis due to Trichophyton soudanense. Mycoses (2003) 0.75
Acroangiodermatitis (pseudo-Kaposi sarcoma) associated with verrucous hyperplasia induced by suction-socket lower limb prosthesis. J Cutan Pathol (2005) 0.75
Neuroblastoma-like neurilemoma: an additional case. J Dermatol (2008) 0.75
Global developmental delay, osteopenia and ectodermal defect: a new syndrome. Brain Dev (2005) 0.75
Compound melanocytic nevus associated with dermatofibroma: an additional case. J Cutan Pathol (2007) 0.75
The doppel (Dpl) protein influences in vitro migration capability in astrocytoma-derived cells. Cell Oncol (2008) 0.75
Superficial Acral Fibromyxoma of the Toe: Unusual Location of the Mixoid Variant. Am J Dermatopathol (2017) 0.75
Tinea corporis purpurica and onychomycosis caused by Trichophyton violaceum. Mycoses (2011) 0.75
Computer-assisted melanoma diagnosis: a new integrated system. Melanoma Res (2015) 0.75
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis. Rheumatol Int (2009) 0.75
Focal cortical dysplasia type 1b as a cause of severe epilepsy with multiple independent spike foci. Brain Dev (2007) 0.75
A case of primary cutaneous actinomycosis. Acta Derm Venereol (2002) 0.75
Kabuki syndrome with trichrome vitiligo, ectodermal defect and hypogammaglobulinemia A and G. Brain Dev (2006) 0.75
Disseminated Mediterranean Kaposi sarcoma treated with low-dose recombinant interferon alfa-2a. J Am Acad Dermatol (2003) 0.75
Objective follow-up of atypical melanocytic skin lesions: a retrospective study. Arch Dermatol Res (2010) 0.75
Benign lymphoepithelial lesion associated with squamous cell carcinoma of the skin: an immunohistochemical and molecular genetic study. J Cutan Pathol (2002) 0.75
Hypohidrotic ectodermal dysplasia and intrathoracic neuroblastoma. Pediatr Dermatol (2007) 0.75
Influence of Ambient Stressors and Time Constraints on Diagnostic Accuracy of Borderline Pigmented Skin Lesions. Dermatology (2015) 0.75
[Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques]. Radiol Med (2004) 0.75